(1)
DONOR KIR3DL1 RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION: KIR3DL1 With HLA-Bw4-80I Reduces Leukemia Relapse. Mediterr J Hematol Infect Dis 2021, 13 (1), e2021005 . https://doi.org/10.4084/mjhid.2021.005.